Sign In
Buy CNC
$61.02
+0.380 (+0.627%)
At Close: Jun 18, 2026
Centene vice chairman talks CMS changes, the Alzheimer's drug, and COVID-19 hospitalizations
03:56pm, Wednesday, 12'th Jan 2022
Sarah London, Vice Chairman of Centene, joins Yahoo Finance Live to talk about Centene's health care initiatives, CMS changes, and how they are handling COVID-19 hospitalizations. Don't Miss: Valley o
UnitedHealth (UNH) Unit Invests to Improve Members' Eye Health
03:02pm, Wednesday, 12'th Jan 2022 Zacks Investment Research
UnitedHealth Group's (UNH) business, UnitedHealthcare, offers discount programs and invests in school districts in an effort to improve the eye health of its vision members.
REMINDER: CENTENE CORPORATION'S 2021 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS CONFERENCE CALL
05:23pm, Monday, 10'th Jan 2022
ST. LOUIS, Jan. 10, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2021 fourth quarter and full-year financial results at approximately 6 a.m. E
Here's Why You Should Retain Centene (CNC) in Your Portfolio
05:20pm, Friday, 07'th Jan 2022 Zacks Investment Research
Centene (CNC) is well poised for growth on the back of improving revenues, continuous expansion plans for the MA business and sufficient cash-generating abilities.
Humana (HUM) Cuts Medicare Enrollment Outlook, Tumbles 19.4%
02:42pm, Friday, 07'th Jan 2022 Zacks Investment Research
Humana (HUM) expects Group Medicare Advantage membership to remain flat in 2022, with competitive pricing possibly playing a crucial role.
Here's Why You Should Retain Centene (CNC) in Your Portfolio
01:49pm, Friday, 07'th Jan 2022
Centene (CNC) is well poised for growth on the back of improving revenues, continuous expansion plans for the MA business and sufficient cash-generating abilities.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
11:20am, Wednesday, 05'th Jan 2022 Zacks Investment Research
Sector ETF report for RYH
Concurrent Technologies Sees 2021 Rev, Profitability Slightly Above Market Views
07:40am, Wednesday, 05'th Jan 2022 MarketWatch
By Kyle Morris Concurrent Technologies PLC said Wednesday that it expects to report revenue and profitability slightly above market expectations for 2021,
Humana (HUM) Enhances Value-Based Care With Vancouver Clinic
08:56pm, Tuesday, 04'th Jan 2022 Zacks Investment Research
Humana (HUM) collaborates with Vancouver Clinic to boost its Medicare Advantage portfolio.
Molina Healthcare (MOH) Buys Cigna's TX Medicaid Contracts
08:53pm, Tuesday, 04'th Jan 2022 Zacks Investment Research
Molina Healthcare (MOH) purchases the Texas Medicaid contracts of Cigna to bolster its presence in the Texas region.
CENTENE TO PRESENT AT 40TH ANNUAL JP MORGAN HEALTHCARE CONFERENCE
04:15pm, Tuesday, 04'th Jan 2022
ST. LOUIS, Jan. 4, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the JP Morgan 40th Annual Healthcare Conference, to be held virtually January 10-13, 2022. Ce
Why iTeos Therapeutics Topped the Market Today
09:46pm, Monday, 03'rd Jan 2022 The Motley Fool
The stock is about to become a component of a high-profile index.
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?
11:20am, Monday, 03'rd Jan 2022 Zacks Investment Research
Smart Beta ETF report for RYH
Centene (CNC) Receives DMHC Approval for Magellan Acquisition
04:15pm, Friday, 31'st Dec 2021 Zacks Investment Research
Centene's (CNC) acquisition with Magellan Health is likely to close on Jan 4, 2022, around a year after the deal announcement.
Centene (CNC) Receives DMHC Approval for Magellan Acquisition
01:00pm, Friday, 31'st Dec 2021
Centene's (CNC) acquisition with Magellan Health is likely to close on Jan 4, 2022, around a year after the deal announcement.
